Pfizer has released footage of a potential Pfizer coronavirus vaccine coming out on the production line – as the giant drug aims to have 100 million doses by the end of the year.
The Manhattan-based company told the Mail on Sunday it had already made “hundreds of thousands of doses” of the drug as it prepares to seek emergency use in the US in November.
The firm’s UK boss, Ben Osborn, also said in the paper that scientists in the British primary lab were also digging up drugs that could provide a potential complete cure for Covid-19, as opposed to a vaccine. Just avoid it.
Osborn said the company is making a large stockpile of the current Belgian vaccine candidate who is “at risk and on the scale,”; calling it “extremely exciting.”
“The hope here is that it is important for us to have a drug that interferes with the virus and ultimately prevents a patient’s condition from getting worse,” he told Mail’s financial site, This is Money.
“It was great to see the first vial coming from the manufacturing line. It brought a huge smile to my face to see all this work really resulting in a product,” he said.
But “we can only go as fast as science allows us,” he stressed.
Pfizer expects to find out if the vaccine works or not by the end of this month, but the company still needs to prove that the shooting is safe and can be developed properly to seek so-called emergency use permission, CEO Albert said. Bourla on Friday.
If safe, he expects his company to seek emergency use in the US in the third week of November.
“We run at the speed of science,” he said.